Rekvina Laboratories Limited has disclosed the official voting results for its Extra-Ordinary General Meeting (EGM) held on April 10, 2026, pursuant to Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting, conducted at the company's registered office in Vadodara, Gujarat, saw unanimous approval of all six proposed resolutions by shareholders.

Meeting Overview and Attendance

The EGM was successfully conducted on Friday, April 10, 2026, at 11:30 A.M. at 36, Sampatrao Colony, Next to Royal Hotel, Alkapuri, Vadodara, Gujarat. The meeting was chaired by Mr. Amit Mukesh Shah, Chairman & Managing Director, with comprehensive board representation and professional oversight.

Voting Results and Shareholder Participation

The voting process was conducted through remote e-voting facilitated by Central Depository Services Limited (CDSL), with the e-voting period commencing on April 6, 2026, at 9:00 A.M. and concluding on April 9, 2026, at 5:00 P.M. Mr. Suhas Bhattbhatt served as the appointed Scrutinizer to oversee the voting process and ensure transparency.

Key Resolutions Approved

All six critical resolutions were unanimously approved by the shareholders, focusing on capital enhancement and operational flexibility:

• Increase in Authorised Share Capital and alteration of Capital Clause of the Memorandum of Association
• Alteration of Articles of Association of the Company
• Investments, Loans, Guarantees and Security in excess of limits specified under Section 186 of Companies Act, 2013
• Approval of Related Party Transactions proposed to be entered into by the Company
• Issuance and Allotment of Equity Shares by way of preferential issue on private placement basis for consideration other than cash
• Issuance and Allotment of Equity Shares by way of preferential issue on private placement basis for cash consideration to non-promoter category

Regulatory Compliance and Documentation

The company has fulfilled its regulatory obligations by submitting the voting results along with the consolidated Scrutinizer's report to BSE Limited. The documentation includes comprehensive voting breakdowns across promoter and public categories, with detailed percentage calculations and compliance confirmations. The voting results and Scrutinizer's report have also been uploaded on the company's official website for transparency.

The unanimous approval of all resolutions demonstrates strong shareholder confidence in Rekvina Laboratories' strategic direction and capital restructuring initiatives, positioning the company for enhanced operational flexibility and growth opportunities.

Rekvina Laboratories Limited has officially notified BSE Limited that it is claiming exemption from submitting the Annual Secretarial Compliance Report for the financial year ended 31st March, 2026. The communication, dated 06.04.2026, was addressed to the Department of Corporate Services at BSE.

Regulatory Exemption Details

The company has invoked Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which provides specific exemptions for smaller listed entities. Under this regulation, companies meeting certain financial criteria are exempt from various corporate governance provisions.

Scope of Exemptions

The exemption covers extensive corporate governance provisions under SEBI regulations. The company is relieved from compliance with multiple regulations and specific clauses that typically apply to larger listed entities.

Exempt Regulations:

• Regulations 17, 17A, 18, 19, 20, 21, 22, 23, 24, 24A, 25, 26, 26A, 27
• Clauses (b) to (i) and (t) of sub-regulation (2) of regulation 46
• Para C, D and E of Schedule V

Company Information

Rekvina Laboratories Limited operates under CIN L24231GJ1988PLC01145 with its registered office located at 36, Sampatrao Colony, Next to Royal Hotel, Alkapuri, Baroda. The notification was signed by Director Surbhit Mukesh Shah (DIN: 01993300), confirming the company's position regarding the non-applicability of the Annual Secretarial Compliance Report requirement.

The company has requested BSE to acknowledge this exemption claim and take note of its regulatory status for the financial year 2026.